Equol Enhances Apoptosis-inducing Activity of Genistein by Increasing Bax/Bcl-xL Expression Ratio in MCF-7 Human Breast Cancer Cells

Nutrition and Cancer

Volumn 69, Issue 8, 2017, Pages 1300-1307

  Ono, Misaki ^a   Ejima, Kaoru ^a   Higuchi, Takako ^a   Takeshima, Mikako ^a   Wakimoto, Rei ^a   Nakano, Shuji ^a  

^a NAKAMURA GAKUEN UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EQUOL; ESTROGEN RECEPTOR; GENISTEIN; MAMMALIAN TARGET OF RAPAMYCIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BAX; PROTEIN BCL XL; PROTEIN KINASE B; BAX PROTEIN, HUMAN; BCL2L1 PROTEIN, HUMAN; MTOR PROTEIN, HUMAN; PROTEIN BCL X; TARGET OF RAPAMYCIN KINASE;

AKT/MTOR SIGNALING; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; BAX BCL XL EXPRESSION RATIO; CANCER INHIBITION; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; ESTROGEN RECEPTOR POSITIVE BREAST CANCER; FLUORESCENCE ACTIVATED CELL SORTING; G1 PHASE CELL CYCLE CHECKPOINT; G2 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION; GENETIC PARAMETERS; HUMAN; HUMAN CELL; HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 POSITIVE BREAST CANCER; IC50; MCF-7 CELL LINE; MDA-MB-468 CELL LINE; PROTEIN PHOSPHORYLATION; SK-BR-3 CELL LINE; TRIPLE NEGATIVE BREAST CANCER; BREAST TUMOR; CELL CYCLE; DRUG EFFECT; FEMALE; FLOW CYTOMETRY; GENETICS; METABOLISM;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; BREAST NEOPLASMS; CELL CYCLE; EQUOL; FEMALE; FLOW CYTOMETRY; GENISTEIN; HUMANS; MCF-7 CELLS; PROTO-ONCOGENE PROTEINS C-AKT; TOR SERINE-THREONINE KINASES;

EID: 85032808186     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2017.1367945     Document Type: Article

References (44)

1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, et al.: Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136, E359–E386, 2015. doi: 10.1002/ijc.29210
2. Pike AC, Brzozowski AM, Hubbard RE, Bonn T, Thorsell AG, et al.: Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist. EMBO J 18, 4608–4018, 1999. doi: 10.1093/emboj/18.17.4608
3. Dong JY, and Qin LQ, : Soy isoflavones consumption and risk of breast cancer incidence or recurrence: A meta-analysis of prospective studies. Breast Cancer Res Treat 125, 315–323, 2011. doi: 10.1007/s10549-010-1270-8
4. Chen MN, Rao YH, Zheng Y, Wei SQ, Li Y, et al.: Association between Soy Isoflavone Intake and Breast Cancer Risk for Pre- and Post-Menopausal Women: A Meta-Analysis of Epidemiological Studies. Plos One 9, 2014. doi: ARTN e8928810.1371/journal.pone.0089288
5. Messina M, Nagata C, Wu AH, : Estimated Asian adult soy protein and isoflavone intakes. Nutr Cancer 55, 1–12, 2006. doi: 10.1207/s15327914nc5501_1
6. van der Schouw YT, Kreijkamp-Kaspers S, Peeters PHM, Keinan-Boker L, Rimm EB, et al.: Prospective study on usual dietary phytoestrogen intake and cardiovascular disease risk in Western women. Circulation 111, 465–471, 2005. doi: 10.1161/01.Cir.0000153814.87631.B0
7. Iwasaki M, Inoue M, Otani T, Sasazuki S, Kurahashi N, et al.: Plasma isoflavone level and subsequent risk of breast cancer among Japanese women: A nested case-control study from the Japan Public Health Center-based prospective study group. J Clin Oncol 26, 1677–1683, 2008. doi: 10.1200/JCO.2007.13.9964
8. Allred CD, Allred KF, Ju YH, Virant SM, and Helferich WG, : Soy diets containing varying amounts of genistein stimulate growth of estrogen-dependent (MCF-7) tumors in a dose-dependent manner. Cancer Res 61, 5045–5050, 2001.
9. Hsieh CY, Santell RC, Haslam SZ, and Helferich WG, : Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo. Cancer Res 58, 3833–3838, 1998.
10. Peterson G, and Barnes S, : Genistein inhibition of the growth of human breast cancer cells: Independence from estrogen receptors and the multi-drug resistance gene. Biochem Biophys Res Commun 179, 661–667, 1991.
11. Shao ZM, Wu J, Shen ZZ, and Barsky SH, : Genistein exerts multiple suppressive effects on human breast carcinoma cells. Cancer Res 58, 4851–4857, 1998.
12. Andres S, Abraham K, Appel KE, and Lampen A, : Risks and benefits of dietary isoflavones for cancer. Crit Rev Toxicol 41, 463–506, 2011. doi: 10.3109/10408444.2010.541900
13. Paruthiyil S, Cvoro A, Tagliaferri M, Cohen I, Shtivelman E, et al.: Estrogen receptor beta causes a G2 cell cycle arrest by inhibiting CDK1 activity through the regulation of cyclin B1, GADD45A, and BTG2. Breast Cancer Research and Treatment 129, 777–784, 2011. doi: 10.1007/s10549-010-1273-5
14. Jiang Y, Gong P, Madak-Erdogan Z, Martin T, Jeyakumar M, et al.: Mechanisms enforcing the estrogen receptor beta selectivity of botanical estrogens. FASEB J 27, 4406–4418, 2013. doi: 10.1096/fj.13-234617
15. Uifalean A, Schneider S, Ionescu C, Lalk M, and Iuga CA, : Soy isoflavones and breast cancer cell lines: Molecular mechanisms and future perspectives. Molecules 21, E13, 2015. doi: 10.3390/molecules21010013
16. Peterson G, : Evaluation of the biochemical targets of genistein in tumor cells. J Nutr 125, 784S–789S, 1995
17. Setchell KD, Clerici C, Lephart ED, Cole SJ, Heenan C, et al.: S-equol, a potent ligand for estrogen receptor beta, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora. Am J Clin Nutr 81, 1072–1079, 2005
18. Setchell KD, and Clerici C, : Equol: pharmacokinetics and biological actions. J Nutr 140, 1363S–1368S, 2010. doi: 10.3945/jn.109.119784
19. Verma SP, and Goldin BR, : Effect of soy-derived isoflavonoids on the induced growth of MCF-7 cells by estrogenic environmental chemicals. Nutr Cancer 30, 232–239, 1998. doi: 10.1080/01635589809514669
20. Onoda A, Ueno T, Uchiyama S, Hayashi S, Kato K, et al.: Effects of S-equol and natural S-equol supplement (SE5-OH) on the growth of MCF-7 in vitro and as tumors implanted into ovariectomized athymic mice. Food Chem Toxicol 49, 2279–2284, 2011. doi: 10.1016/j.fct.2011.06.027
21. Ju YH, Fultz J, Allred KF, Doerge DR, and Helferich WG, : Effects of dietary daidzein and its metabolite, equol, at physiological concentrations on the growth of estrogen-dependent human breast cancer (MCF-7) tumors implanted in ovariectomized athymic mice. Carcinogenesis 27, 856–863, 2006. doi: 10.1093/carcin/bgi320
22. Choi EJ, and Kim GH, : Anticancer mechanism of equol in 7, 12-dimethylbenz(a)anthracene-treated animals. Int J Oncol 39, 747–754, 2011. doi: 10.3892/ijo.2011.1067
23. Lu Z, Zhou R, Kong Y, Wang J, Xia W, et al.: S-equol, a secondary metabolite of natural anticancer isoflavone daidzein, inhibits prostate cancer growth in vitro and in vivo, though activating the Akt/FOXO3a pathway. Curr Cancer Drug Targets, 16, 455–465, 2015.
24. Liang XL, Li M, Li J, and Wang XL, : Equol induces apoptosis in human hepatocellular carcinoma SMMC-7721 cells through the intrinsic pathway and the endoplasmic reticulum stress pathway. Anticancer Drugs 25, 633–640, 2014. doi: 10.1097/CAD.0000000000000085
25. Lyn-Cook BD, Stottman HL, Yan Y, Blann E, Kadlubar FF, et al.: The effects of phytoestrogens on human pancreatic tumor cells in vitro. Cancer Lett 142, 111–9, 1999
26. Yang ZP, Zhao Y, Huang F, Chen J, Yao YH, et al.: Equol inhibits proliferation of human gastric carcinoma cells via modulating Akt pathway. World J Gastroenterol 21, 10385–10399, 2015. doi: 10.3748/wjg.v21.i36.10385
27. Ono M, Koga T, Ueo H, and Nakano S, : Effects of dietary genistein on hormone-dependent rat mammary carcinogenesis induced by ethyl methanesulphonate. Nutr Cancer 64, 1204–1210, 2012. doi: 10.1080/01635581.2012.718035
28. Ono M, Ejima K, Takeshima M, Higuchi T, Wakimoto R, et al.: Mechanistic study of synergistic interaction between genistein and equol in MCF-7 human breast cancer cells in vitro. Cancer Research 75, 2015. doi: 10.1158/1538-7445.AM2015-909
29. Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, et al.: A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 10, 515–527, 2006. doi: 10.1016/j.ccr.2006.10.008
30. Ono M, Higuchi T, Takeshima M, Chen C, and Nakano S, : Differential anti-tumor activities of curcumin against Ras- and Src-activated human adenocarcinoma cells. Biochem Biophys Res Commun 436, 186–191, 2013. doi: 10.1016/j.bbrc.2013.05.071
31. Setchell KD, Brown NM, Zhao X, Lindley SL, Heubi JE, et al.: Soy isoflavone phase II metabolism differs between rodents and humans: implications for the effect on breast cancer risk. Am J Clin Nutr 94, 1284–1294, 2011. doi: 10.3945/ajcn.111.019638
32. Yuan JP, Wang JH, and Liu X, : Metabolism of dietary soy isoflavones to equol by human intestinal microflora–implications for health. Mol Nutr Food Res 51, 765–781, 2007. doi: 10.1002/mnfr.200600262
33. Bolca S, Urpi-Sarda M, Blondeel P, Roche N, Vanhaecke L, et al.: Disposition of soy isoflavones in normal human breast tissue. Am J Clin Nutr 91, 976–84, 2010. doi: 10.3945/ajcn.2009.28854
34. Chen M, Rao Y, Zheng Y, Wei S, Li Y, et al.: Association between soy isoflavone intake and breast cancer risk for pre- and post-menopausal women: a meta-analysis of epidemiological studies. PLoS One 9, e89288, 2014. doi: 10.1371/journal.pone.0089288
35. Hedlund TE, Johannes WU, and Miller GJ, : Soy isoflavonoid equol modulates the growth of benign and malignant prostatic epithelial cells in vitro. Prostate 54, 68–78, 2003. doi: 10.1002/pros.10137
36. Liu YL, Zhang GQ, Yang Y, Zhang CY, Fu RX, et al.: Genistein induces G2/M arrest in gastric cancer cells by increasing the tumor suppressor PTEN expression. Nutr Cancer 65, 1034–1041, 2013. doi: 10.1080/01635581.2013.810290
37. Han J, Kurita Y, and Isoda H, : Genistein-induced G2/M cell cycle arrest of human intestinal colon cancer Caco-2 cells is associated with Cyclin B1 and Chk2 down-regulation. Cytotechnology 65, 973–978, 2013. doi: 10.1007/s10616-013-9592-0
38. Prietsch RF, Monte LG, da Silva FA, Beira FT, Del Pino FA, et al.: Genistein induces apoptosis and autophagy in human breast MCF-7 cells by modulating the expression of proapoptotic factors and oxidative stress enzymes. Mol Cell Biochem 390, 235–242, 2014. doi: 10.1007/s11010-014-1974-x
39. Rajah TT, Peine KJ, Du N, Serret CA, and Drews NR, : Physiological concentrations of genistein and 17beta-estradiol inhibit MDA-MB-231 breast cancer cell growth by increasing BAX/BCL-2 and reducing pERK1/2. Anticancer Res 32, 1181–1191, 2012
40. Jin S, Zhang QY, Kang XM, Wang JX, and Zhao WH, : Daidzein induces MCF-7 breast cancer cell apoptosis via the mitochondrial pathway. Ann Oncol 21, 263–268, 2010. doi: 10.1093/annonc/mdp499
41. Sakamoto T, Horiguchi H, Oguma E, and Kayama F, : Effects of diverse dietary phytoestrogens on cell growth, cell cycle and apoptosis in estrogen-receptor-positive breast cancer cells. J Nutr Biochem 21, 856–864, 2010. doi: 10.1016/j.jnutbio.2009.06.010
42. Charalambous C, Pitta CA, and Constantinou AI, : Equol enhances tamoxifen's anti-tumor activity by induction of caspase-mediated apoptosis in MCF-7 breast cancer cells. BMC Cancer 13, 238, 2013. doi: 10.1186/1471-2407-13-238
43. Ciruelos Gil EM, : Targeting the PI3K/AKT/mTOR pathway in estrogen receptor-positive breast cancer. Cancer Treat Rev 40, 862–871, 2014. doi: 10.1016/j.ctrv.2014.03.004
44. Chen J, Duan Y, Zhang X, Ye Y, Ge B, et al.: Genistein induces apoptosis by the inactivation of the IGF-1R/p-Akt signaling pathway in MCF-7 human breast cancer cells. Food Funct 6, 995–1000, 2015. doi: 10.1039/c4fo01141d